[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368314-105":59,"doc-detail-368314-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pan-cancer-analysis-of-oncogene-sfxn1-to-identify-its-prognostic-and-immunological-roles-in-lung-adenocarcinoma","Pan-cancer analysis of oncogene SFXN1 to identify its prognostic and immunological roles in lung adenocarcinoma","","Cancer incidence and mortality continue to rise, increasing the need for mechanistic studies and biomarkers. This work focuses on sideroflexin 1 (SFXN1), a member of the SFXN family involved in transporting serine to mitochondria and participating in one-carbon metabolism. Using public bioinformatics resources including TCGA, Human Protein Atlas, GEPIA, and UALCAN, the study evaluates expression patterns, prognostic value, and relationships with immune infiltration across tumor types. SFXN1 is differentially expressed, correlates with clinicopathological features, links to immune cell infiltration and immune checkpoint genes, and shows functional effects in lung adenocarcinoma where silencing reduces proliferation, migration, and invasion while increasing apoptosis. The findings support SFXN1 as a potential diagnostic/prognostic biomarker and therapeutic target for cancer immunotherapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pan-cancer-analysis-of-oncogene-sfxn1-to-identify-its-prognostic-and-immunological-roles-in-lung-adenocarcinoma/368314/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pan-cancer-analysis-of-oncogene-sfxn1-to-identify-its-prognostic-and-immunological-roles-in-lung-adenocarcinoma/368314.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is SFXN1 and why is it relevant to cancer research?","Question",{"text":112,"@type":113},"SFXN1 is a sideroflexin family member involved in transporting serine to mitochondria and participating in one-carbon metabolism. It has been linked to multiple malignancies and may influence proliferation and processes such as ferroptosis-related pathways.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which data sources were used to analyze SFXN1 across cancers?",{"text":117,"@type":113},"The study used public databases including The Cancer Genome Atlas (TCGA), Human Protein Atlas (HPA), Gene Expression Profiling Interactive Analysis (GEPIA), and University of Alabama at Birmingham Cancer Data Analysis Portal (UALCAN).",{"name":119,"@type":110,"acceptedAnswer":120},"What did loss-of-function experiments show in lung adenocarcinoma?",{"text":121,"@type":113},"Silencing SFXN1 decreased cell proliferation, migration, and invasion while increasing apoptosis in lung adenocarcinoma cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368314,1791034222,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","ONCOLOGY REPORTS 53: 50, 2025  \nPan‑cancer analysis of oncogene SFXN1 to identify its prognostic and immunological roles in lung adenocarcinoma  \nLIMING ZHANG 1 , SHAOQIANG WANG2 and LINA WANG3  \n1Department of Thoracic Surgery, Weifang Second People's Hospital, Weifang, Shandong 261041, P.R. China; 2Department of Thoracic Surgery, Weifang People's Hospital, Weifang, Shandong 261000, P.R. China; 3Medical Research Center, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272029, P.R. China  \nReceived September 25, 2024; Accepted January 14, 2025  \nDOI: 10. 3892/or.2025.8883  \nAbstract. As cancer incidence and mortality rates continue to rise, the urgency for research in this field has increased globally. Sideroflexin 1 (SFXN1), a pivotal member of the SFXN protein family, serves a crucial role in transporting serine to mitochondria and participates in one‑carbon metabolism, thereby influencing cell proliferation and differentiation . While SFXN1 is linked to lung cancer and glioma, its role in other malignancies remains largely unexplored. Utilizing The Cancer Genome Atlas, Human Protein Atlas, Gene Expression Profiling Interactive Analysis and University of Alabama at Birmingham Cancer Data Analysis Portal databases, the present study investi‑ gated the expression patterns, prognostic implications and association with immune cell infiltration of SFXN1 . The present findings revealed that SFXN1 was differentially expressed across various tumor types, and exhibited signifi‑ cant associations with clinicopathological features and patient prognosis . Through immune infiltration analysis, a significant correlation between SFXN1 and T cells, B cells and immune checkpoint genes was established in numerous tumor types. Notably, loss‑of‑function experiments demon‑ strated that silencing of SFXN1 decreased cell proliferation, migration and invasion, while simultaneously increasing apoptosis in lung adenocarcinoma cells. Collectively, these findings suggested that SFXN1 expression could potentially serve as a biomarker for tumor diagnosis and prognosis, also emerging as a novel therapeutic target in cancer immu‑ notherapy. The present study highlights the critical role of SFXN1 in cancer biology and paves the way for future translational efforts aimed at leveraging its potential in clinical oncology.  \nCorrespondence to: Dr Lina Wang, Medical Research Center, Affiliated Hospital of Jining Medical University, Jining Medical University, 89 Guhuai Road, Jining, Shandong 272029, P.R. China  \nE‑[mail: wanglina_china@163.com](mail: wanglina_china@163.com)  \nKey words: sideroflexin 1, pan‑cancer, prognosis, immune infiltration, bioinformatics analysis  \nIntroduction  \nGlobal statistics indicate that cancer has become the primary cause of death, posing a significant threat to human health (1) . Despite advancements in cancer treatment modalities, including surgery, chemotherapy, targeted therapy and immu‑ notherapy, which have notably improved patient survival rates, individuals with advanced lung cancer continue to face poor overall survival (OS) rates (2) . Consequently, there is a need to explore more effective strategies for the prevention, early detection and treatment of cancer. Additionally, understanding the pathophysiological processes that initiate and drive cancer progression is crucial, offering both theoretical insights and practical applications.  \nThe inner mitochondrial membrane of eukaryotic cells houses a class of transmembrane proteins referred to as sidero‑ flexins (SFXNs), which were previously presumed to function solely as iron‑utilizing metabolite transporters with limited known molecular roles (3,4) . Serine, rich in one‑carbon units, serves a pivotal role in supplying the one‑carbon units essential for anabolic processes in dividing human cells (5,6) . Mitochondrial serine metabolism predominantly fulfills this requirement, with cytosolic serine‑driven one‑carbon metabo‑ lism ","cbCaisLqUgKfHQHE","https://ap.wps.com/l/cbCaisLqUgKfHQHE","pdf",20368415,18,"English","# Introduction\n## SFXN1 and one-carbon/mitochondrial iron metabolism\n## Rationale for exploring prognosis and immune roles\n\n# Materials and methods","[{\"question\":\"What is SFXN1 and why is it relevant to cancer research?\",\"answer\":\"SFXN1 is a sideroflexin family member involved in transporting serine to mitochondria and participating in one-carbon metabolism. It has been linked to multiple malignancies and may influence proliferation and processes such as ferroptosis-related pathways.\"},{\"question\":\"Which data sources were used to analyze SFXN1 across cancers?\",\"answer\":\"The study used public databases including The Cancer Genome Atlas (TCGA), Human Protein Atlas (HPA), Gene Expression Profiling Interactive Analysis (GEPIA), and University of Alabama at Birmingham Cancer Data Analysis Portal (UALCAN).\"},{\"question\":\"What did loss-of-function experiments show in lung adenocarcinoma?\",\"answer\":\"Silencing SFXN1 decreased cell proliferation, migration, and invasion while increasing apoptosis in lung adenocarcinoma cells.\"}]","Pan-cancer analysis of oncogene SFXN1 to identify its prognostic and immunological roles in lung adenocarcinoma | PDF",1790176251,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4d3ccc2016b7cd1cc7634be3870cf58.webp",983,1357,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a611bed5ea72c12730695d6c8074d009.webp",982,1356,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c386ebd494c3d0534a60d0e4f723979e.webp",981,1354,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/00d60838046e3f9065166f22e533dea6.webp",980,1353]